$BHC

Bausch Health Companies Inc.

  • New York Stock Exchange
  • Health Technology
  • Pharmaceuticals: Other

PRICE

$15.35 ▲0.524%

Extented Hours

VOLUME

3,798,804

DAY RANGE

15.02 - 15.51

52 WEEK

11.15 - 31.97

Echofin Members Consensus

JA
jackiechen #ivtrades Join team
recently

New buy signal for $BHC

profile
dros #droscrew Join team
recently

$BHC 18SEP20 $17.5 Cs - Najarian

profile
Marcosx #ivtrades Join team
recently

looks liek Najarian butchered $BHC

MI
MichaelS #ivtrades Join team
recently

@mitch1588 you referring to the 23k BHC 8/28 17 calls?

profile
mitch1588 #ivtrades Join team
recently

Nice volume in $BHC

profile
matthewnitto #droscrew Join team
recently

back at it with BHC huh

profile
dros #droscrew Join team
recently

$BHC 28AUG20 $17 Cs // 18k+ trading vs 3163 OI

profile
dros #droscrew Join team
recently

the BHC is very reasonable

profile
dros #droscrew Join team
recently

$BHC 28AUG20 $17 Cs // 18k+ trading vs 3163 OI

profile
dros #droscrew Join team
recently

naja pumping mrk and bhc next week calls

profile
ivtrades-Chris #ivtrades Join team
recently

2194 $BHC Aug20 28th 17.0 Calls trade $0.41 (FT Theo=0.42) ASKSIDE [NOM] 14:54:47 IV=45.6% -5.6 OPENING Vol=3123, OI=289

profile
ivtrades-Chris #ivtrades Join team
recently

2144 $BHC Aug20 28th 17.0 Calls trade $0.41 (FT Theo=0.42) ASKSIDE NOM 14:54:48 IV=45.6% -5.6 OPENING Vol=3123, OI=289,

profile
dros #droscrew Join team
recently

12k+ $BHC 21AUG20 $18.5 Cs trading .35-.5

profile
Pyrognosis #droscrew Join team
recently

was in the red a long time and bailed out green in BHC. Too much hard to parse news with the eye care spinoff

profile
Pyrognosis #droscrew Join team
recently

i just sold BHC the other day

profile
Navneet #droscrew Join team
recently

should i get BHC 21 call ?

profile
matthewnitto #droscrew Join team
recently

its things like $BHC why i always sell a pop

profile
Navneet #droscrew Join team
recently

can i enter tomorrow BHC leaps ?

profile
dros #droscrew Join team
recently

I’m sure matt mentioned the BHC move today

profile
Marcosx #ivtrades Join team
recently

have some spec NLOK For earnings hopefully does a BHC or better yet a PINS

profile
Marcosx #ivtrades Join team
recently

the BHC Leaps finally showing signs of life

profile
Pyrognosis #droscrew Join team
recently

out BHC +32%

profile
Pyrognosis #droscrew Join team
recently

$BHC Bausch Health Companies (BHC) on Thursday posted a Q2 GAAP net loss of $0.92 per share, compared with a loss of $0.49 per share a year earlier. Analysts polled by Capital IQ had forecast a loss of $0.52 per share.

profile
matthewnitto #ivtrades Join team
recently

solid ganner in BHC

profile
Pyrognosis #droscrew Join team
recently

Anyone still holding the BHC LEAPS from months ago will have a nice morning.

profile
thegiz18 #ivtrades Join team
recently

$BHC 21Aug $18C on 7/27 were 1.05 will be over $7 if current jump holds

profile
thegiz18 #ivtrades Join team
recently

Big win for $BHC, stock up over 20% on earnings and plan to spin off eye care as seperate business

profile
thegiz18 #ivtrades Join team
recently

I hve $BHC position also holding over earnings

profile
steve66 #ivtrades Join team
recently

BHC insider buys in May and June

profile
Marcosx #ivtrades Join team
recently

$BHC THEY HAVE Vaccine they will cure it with glasses

profile
chago #ivtrades Join team
recently

anybody holding $BHC through earnings?

profile
Marcosx #ivtrades Join team
recently

$bhc Reports manana

profile
thegiz18 #ivtrades Join team
recently

Those $BHC Aug $18C ar nearing a double since yesterday

profile
Marcosx #ivtrades Join team
recently

yeah BHC chart righting itself a bit

JO
johnsou2 #ivtrades Join team
recently

great find on that BHC chris

JO
johnsou2 #ivtrades Join team
recently

bhc rocking

profile
Marcosx #ivtrades Join team
recently

There is support at 17 to sell a put sadly my knowledge of the fundamentals not good enough BHC here but sets up well

profile
thegiz18 #ivtrades Join team
recently

$BHC 21Aug20 $18C not a bad way to play it into earnings, $1.05 entry

profile
DimaC #ivtrades Join team
recently

talking about $BHC

profile
thegiz18 #ivtrades Join team
recently

I'm in $BHC shares

JO
johnsou2 #ivtrades Join team
recently

i took that BHC play

profile
ivtrades-Chris #ivtrades Join team
recently

$BHC.... another vaccine play?

profile
matthewnitto #droscrew Join team
recently

10k $BHC Jan21 21 calls trade 1.55

profile
matthewnitto #droscrew Join team
recently

10k $BHC Jan21 21 calls trade 1.55

profile
ivtrades-Chris #ivtrades Join team
recently

10004 $BHC Jan21 21.0 Calls trade $1.558 (FT Theo=1.46) Above Ask! [MULTI] 14:38:42 IV=54.7% +1.5 OPENING Vol=10k, OI=375,

profile
Pyrognosis #droscrew Join team
recently

$BHC finally moving

profile
Pyrognosis #droscrew Join team
recently

Bank of America Increases Bausch Health Companies $BHC Price Target to $14.00

profile
Pyrognosis #droscrew Join team
recently

an open line call on BHC

Key Metrics

Market Cap

5.43 B

Beta

1.36

Avg. Volume

4.48 M

Shares Outstanding

354.99 M

Yield

0%

Public Float

350.03 M

Next Earnings Date

2020-11-10

Next Dividend Date

Company Information

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

CEO: Joseph C. Papa

Website:

HQ: 2150 St. Elzéar Boulevard West Laval, H7L QC

Related News

  • Smarter Analyst

    Bausch Scores FDA Approval For Preservative Free Allergy Eyedrop

    28 Sep 2020, 08:56
  • PR Newswire

    FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%

    25 Sep 2020, 12:00
  • Benzinga

    The Week Ahead In Biotech: Conference Presentations, IPOs In The Mix

    21 Sep 2020, 01:16
  • Seeking Alpha

    Bausch Health Companies Inc. (BHC) Management Presents at Morgan Stanley Global Healthcare Conference Call Transcript

    18 Sep 2020, 00:03
  • Seeking Alpha

    Bausch Health (BHC) Presents At Morgan Stanley 18th Annual Global Healthcare Conference - Slideshow (NYSE:BHC)

    17 Sep 2020, 23:18